Nothing Special   »   [go: up one dir, main page]

ATE458818T1 - Tet repressor basierte transkriptionale regulatorische proteine - Google Patents

Tet repressor basierte transkriptionale regulatorische proteine

Info

Publication number
ATE458818T1
ATE458818T1 AT00938973T AT00938973T ATE458818T1 AT E458818 T1 ATE458818 T1 AT E458818T1 AT 00938973 T AT00938973 T AT 00938973T AT 00938973 T AT00938973 T AT 00938973T AT E458818 T1 ATE458818 T1 AT E458818T1
Authority
AT
Austria
Prior art keywords
tetracycline
transcriptional regulatory
regulatory proteins
tet repressor
based transcriptional
Prior art date
Application number
AT00938973T
Other languages
English (en)
Inventor
Wolfgang Hillen
Hermann Bujard
Stefanie Urlinger
Original Assignee
Tet Systems Holding Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22479925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE458818(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tet Systems Holding Gmbh & Co filed Critical Tet Systems Holding Gmbh & Co
Application granted granted Critical
Publication of ATE458818T1 publication Critical patent/ATE458818T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00938973T 1999-06-07 2000-06-05 Tet repressor basierte transkriptionale regulatorische proteine ATE458818T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13798699P 1999-06-07 1999-06-07
PCT/IB2000/000886 WO2000075347A2 (en) 1999-06-07 2000-06-05 Tet repressor-based transcriptional regulatory proteins

Publications (1)

Publication Number Publication Date
ATE458818T1 true ATE458818T1 (de) 2010-03-15

Family

ID=22479925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00938973T ATE458818T1 (de) 1999-06-07 2000-06-05 Tet repressor basierte transkriptionale regulatorische proteine

Country Status (8)

Country Link
US (1) US7541446B2 (de)
EP (1) EP1200607B1 (de)
JP (1) JP4836375B2 (de)
AT (1) ATE458818T1 (de)
AU (1) AU783233B2 (de)
CA (1) CA2376665C (de)
DE (1) DE60043889D1 (de)
WO (1) WO2000075347A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030186281A1 (en) * 2001-12-21 2003-10-02 Wolfgang Hillen Modified tetracycline repressor protein compositions and methods of use
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
CA2580515C (en) * 2004-10-04 2017-05-02 National Research Council Of Canada Expression system, components thereof and methods of use
US7935788B2 (en) * 2004-10-04 2011-05-03 National Research Council Of Canada Reverse cumate repressor mutant
WO2006071903A2 (en) * 2004-12-28 2006-07-06 Ptc Therapeutics, Inc. Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions
JP4944781B2 (ja) 2005-09-15 2012-06-06 独立行政法人科学技術振興機構 テトラサイクリン系抗生物質によるタンパク質分解制御法
USRE49583E1 (en) 2005-11-17 2023-07-18 Tet Systems Gmbh & Co. Kg Inducible expression systems
US20080118979A1 (en) 2006-05-15 2008-05-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
AU2007332980A1 (en) * 2006-07-26 2008-06-19 Intrexon Corporation Methods and compositions for treating disease
WO2008114856A1 (ja) 2007-03-14 2008-09-25 Japan Science And Technology Agency 抗生物質によるタンパク質の転写・分解二重制御法
US20080235746A1 (en) 2007-03-20 2008-09-25 Michael James Peters Methods and apparatus for content delivery and replacement in a network
EP2352833B1 (de) 2008-10-01 2013-03-06 TET Systems GmbH & Co. KG Tetracyclin-induzierbare transkriptionskontrollsequenz
CA2740147A1 (en) 2008-10-28 2010-06-03 Pioneer Hi-Bred International, Inc. Sulfonylurea-responsive repressor proteins
US9866609B2 (en) 2009-06-08 2018-01-09 Time Warner Cable Enterprises Llc Methods and apparatus for premises content distribution
CA2796670A1 (en) * 2010-04-23 2011-10-27 Pioneer Hi-Bred International, Inc. Gene switch compositions and methods of use
EP2643459B1 (de) 2010-11-24 2017-09-27 Takara Bio USA, Inc. Transkriptionsmodulatoren mit einem system für induzierbare expression und einer domäne für verteilte proteintransduktion
WO2012103256A2 (en) * 2011-01-26 2012-08-02 Clontech Laboratories, Inc. Enhanced protein transduction
EP2710130B1 (de) 2011-05-19 2022-06-29 Fundación Pública Andaluza Progreso Y Salud Effizient induzierbare lentivirale tet-on-vektor system mit zwei-promotoren
WO2013124474A2 (en) 2012-02-23 2013-08-29 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
WO2017036565A1 (en) 2015-09-04 2017-03-09 Universita' Degli Studi Di Padova Method for generating somatic stem cells
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
CN108474002B (zh) 2015-10-22 2023-05-23 朱诺治疗学有限公司 用于转导的方法、反应剂盒、反应剂和设备
WO2017205852A2 (en) 2016-05-27 2017-11-30 Synthex, Inc. Protein interfaces
US10687115B2 (en) 2016-06-01 2020-06-16 Time Warner Cable Enterprises Llc Cloud-based digital content recorder apparatus and methods
US10129593B2 (en) 2017-03-14 2018-11-13 Charter Communications Operating, Llc Time-based dynamic secondary content placement calls in time-shifted content
WO2018197949A1 (en) 2017-04-27 2018-11-01 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
GB2584210B (en) 2017-11-22 2022-03-16 Synthex Inc Peptides for inhibiting RAD51
US10939142B2 (en) 2018-02-27 2021-03-02 Charter Communications Operating, Llc Apparatus and methods for content storage, distribution and security within a content distribution network
CN113584083A (zh) 2020-04-30 2021-11-02 深圳市深研生物科技有限公司 用于逆转录病毒载体的生产细胞和包装细胞及其制备方法
CN113699147B (zh) 2020-05-22 2023-06-09 深圳市深研生物科技有限公司 基于四环素和Cumate的共调控序列
WO2022204067A1 (en) 2021-03-24 2022-09-29 Dna Twopointo Inc. Tetracycline-inducible expression systems
CN114134160B (zh) * 2021-12-04 2024-01-09 安徽大学 一种四环素调控蛋白突变体基因及其在调控基因表达和环境检测中的应用
US20240228561A1 (en) 2023-01-06 2024-07-11 Life Biosciences, Inc. Methods Of Treating Non-Arteritic Anterior Ischemic Optic Neuropathy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917122A (en) * 1992-08-26 1999-06-29 Byrne; Guerard Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice
EP0705334A1 (de) * 1993-06-14 1996-04-10 Basf Aktiengesellschaft Strenge kontrolle der genexpression in eukaryotischen zellen durch auf tetrazyklin ansprechende promotoren
US5866755A (en) * 1993-06-14 1999-02-02 Basf Aktiengellschaft Animals transgenic for a tetracycline-regulated transcriptional inhibitor
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US6004941A (en) 1993-06-14 1999-12-21 Basf Aktiengesellschaft Methods for regulating gene expression
US5589362A (en) * 1993-06-14 1996-12-31 Basf Aktiengesellschaft Tetracycline regulated transcriptional modulators with altered DNA binding specificities
DE4417598A1 (de) 1994-05-19 1995-12-14 Max Planck Gesellschaft Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
US5851796A (en) 1995-06-07 1998-12-22 Yale University Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes
US6114148C1 (en) 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
US6087166A (en) * 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
DE19851413C2 (de) 1998-11-07 2003-05-22 Wolfgang Hillen Verfahren zur Auswahl von Mutanten von tTA oder rtTA
DE19851415B4 (de) 1998-11-07 2010-11-04 Wolfgang Hillen Mutanter Transaktivator

Also Published As

Publication number Publication date
EP1200607A2 (de) 2002-05-02
AU5419100A (en) 2000-12-28
AU783233B2 (en) 2005-10-06
US7541446B2 (en) 2009-06-02
DE60043889D1 (en) 2010-04-08
CA2376665C (en) 2014-02-25
CA2376665A1 (en) 2000-12-14
WO2000075347A3 (en) 2002-01-10
EP1200607B1 (de) 2010-02-24
JP2003515314A (ja) 2003-05-07
JP4836375B2 (ja) 2011-12-14
US20030208783A1 (en) 2003-11-06
WO2000075347A2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
ATE458818T1 (de) Tet repressor basierte transkriptionale regulatorische proteine
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
ATE311363T1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
DK0515544T3 (da) Steroidsulfataseinhibitorer
DE60035032D1 (de) Verwendung von pioglitazone zur verbesserung der ketose und der azidose
DE69110771D1 (de) Stahlkabel zur Verstärkung von elastomeren Erzeugnissen.
DK1200418T3 (da) Nematodicide trifluorbutener
ATE415979T1 (de) Behandlung mit anti-erbb2 antikörpern
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
DE59803538D1 (de) Wässerige dispersionen enthaltend polyurethane mit carbodiimidgruppen
NO20014673D0 (no) Modulering av vaskul¶r permeabilitet ved hjelp av TIE2- reseptoraktivatorer
IT1285770B1 (it) Composti corticoidei
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE69609864D1 (de) Steroidnitritesterderivate und ihre verwendung als entzündungshemmende medikamente
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
FI955118A (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
DK0652964T3 (da) Promotor af K. lactis transaldolasegenet og anvendelse heraf
ATE222896T1 (de) Substituierte thiazoline und ihre verwendung zur bekämpfung von tierischen schädlingen
CH621224B (de) Mittel zur wachstumshemmung von mikroorganismen und algen.
DE60231137D1 (de) Reca-negativ und rhab-negativ mikroorganismus
DK0656889T3 (da) 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler
FI944563A (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
ATE249230T1 (de) Selektion und verwendung von milchsäurebakterienstämmen, die die nicht- spezifische immunität modulieren können
KR960700243A (ko) 피라졸릴 아크릴산 유도체, 이들의 중간체 및 살균제로서의 용도
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties